Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Memory Disorders × Donepezil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Radiation Injuries 4 Medulloblastoma 3 Choroid Plexus Neoplasms 3 Central Nervous System Neoplasms 3 Brain Neoplasms 3 Astrocytoma 3 Pinealoma 2 Oligodendroglioma 2 Neuroectodermal Tumors, Primitive 2 Meningioma 2 Gliosarcoma 2 Glioma, Subependymal 2 Glioma 2 Glioblastoma 2 Fatigue 2 Ependymoma 2 Depression 2 Craniopharyngioma 2 Cognitive Dysfunction 2 Breast Neoplasms 2 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Sleep Wake Disorders 1 Optic Nerve Glioma 1 Neurotoxicity Syndromes 1 Neoplasm Metastasis 1 Memory Disorders 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Familial ependymoma 1

Interventions

lithium sulfate 1 Surveys and Questionnaires 1 Sugars 1 Pioglitazone 1 Methods 1 Lithium 1 Interviews as Topic 1 Hematologic Tests 1 Echocardiography 1 Donepezil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02822573 2023-09-13

Remember

Wake Forest University Health Sciences

Phase 3 Completed

276 enrolled 33 charts

Breast Neoplasms, Memory Disorders, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡